Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Vela International Fund Bob Sharpe | “Tecan Group (Health Care; TECN) was the third-best contributor in the quarter. Tecan is a Swiss company and a leading provider of laboratory equipment, liquid handling, and OEM instrumentation solutions for in-vitro diagnostics, life science research, and medical device markets. At time of purchase, Tecan had fallen 80% from the stock's 2021 high. The fundamentals for Tecan are finally rebounding from the double-barrel blast of the post-pandemic letdown and the Trump Administration budget-cutting actions hitting medical research funds. The company's recent 1Q26 update shows underlying demand continuing to improve, along with better order growth with a book-to-bill ratio greater than 1.0x across both segments. Management reaffirmed FY26 guidance, and the expected return remains at a healthy double-digit level despite the appreciation this quarter.” | BULL | Q2 2026 Jul 22, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
